TY PHAR.(SZ:002728) Sou Hu Cai Jing·2025-08-12 08:49Core Insights - The stock price of Te Yi Pharmaceutical (002728) closed at 9.47 yuan, with a 0.74% increase and a turnover rate of 7.5% as of August 12, 2025 [1] - The company reported a total revenue of 295 million yuan for Q1 2025, representing a year-on-year growth of 79.29%, and a net profit of 31.57 million yuan, up 244.82% year-on-year [1] Financial Performance - Total revenue for Q1 2025: 295 million yuan, up 79.29% year-on-year [1] - Net profit: 31.57 million yuan, up 244.82% year-on-year [1] - Non-recurring net profit: 31.71 million yuan, up 255.28% year-on-year [1] - Current ratio: 2.023, Quick ratio: 1.305, Debt-to-asset ratio: 19.06% [1] Market Activity - Main capital inflow: 10.01 million yuan, accounting for 3.74% of the total transaction amount [1] - Large single orders net inflow: 9.84 million yuan, accounting for 3.67% of the total transaction amount [1] - Small orders net outflow: 20.20 million yuan, accounting for 7.54% of the total transaction amount [1] Company Overview - Te Yi Pharmaceutical Group Co., Ltd. was established in 2002 and is located in Jiangmen City, primarily engaged in the pharmaceutical manufacturing industry [2] - Registered capital: 5.13 billion yuan, paid-in capital: 2 billion yuan [2] - The company has invested in 8 enterprises and participated in 466 bidding projects [2]